STELLIAM INVESTMENT MANAGEMENT, LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
STELLIAM INVESTMENT MANAGEMENT, LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$19,923,000
-27.9%
572,500
-49.2%
0.66%
-28.4%
Q3 2016$27,635,000
+5.5%
1,127,500
+3.0%
0.92%
+2.1%
Q2 2016$26,192,000
-23.9%
1,095,000
-25.5%
0.91%
-14.9%
Q1 2016$34,398,000
+66.3%
1,470,000
+114.6%
1.06%
+72.6%
Q4 2015$20,680,000685,0000.62%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,344,620$116,393,0006.64%
Consonance Capital Management LP 1,026,902$35,736,0003.92%
FALCON POINT CAPITAL, LLC 801,944$27,908,0003.74%
Credit Capital Investments LLC 72,813$2,534,0003.24%
Crosspoint Capital Strategies, LLC 99,274$3,455,0003.07%
Camber Capital Management LP 611,390$21,276,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 40,901$1,423,0001.04%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 344,103$11,974,0000.83%
STELLIAM INVESTMENT MANAGEMENT, LP 572,500$19,923,0000.66%
AlphaOne Investment Services, LLC 66,105$2,301,0000.64%
View complete list of AMAG PHARMACEUTICALS INC shareholders